Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase III, Randomised Study of Photodynamic Therapy With Metvix Cream 160 mg/g in Comparison With Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma

NCT00469417 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00469417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase III, Randomised Study of Photodynamic Therapy With Metvix Cream 160 mg/g in Comparison With Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma
Lead sponsor
Galderma R&D
Phase
Phase 3
Overall status
Completed
Start date
October 18, 1999
Completion date
April 30, 2005
Enrollment
120 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

superficial basal cell carcinoma